cached image

Mark Stuart Forman, MD, Duke University 1995, PhD, Rockefeller University 1994

Affiliations: 
Experimental Medicine Merck Pharmaceuticals, Lincoln, NJ, United States 
Area:
Molecular pathogeneis of neurodegenerative disease
Website:
http://www.med.upenn.edu/cndr/MarkFormanbio.shtml
Google:
"Mark Forman"
Bio:

http://www.healthgrades.com/directory_search/physician/profiles/dr-md-reports/dr-mark-forman-md-63abc066/hospital-affiliations


EXPERIMENTAL MEDICINE UG4D 034
PO BOX 1000
NORTH WALES, PA 194541099
United States

Mean distance: 14.88 (cluster 24)
 
SNBCP
Cross-listing: Neurotree - Neuropathology Tree

Parents

Sign in to add mentor
Jeffrey A. Golden post-doc Children’s Hospital of Philadelphia / University of Pennsylvania (Neurotree)
Nicholas K. Gonatas post-doc Penn (Neurotree)
 (Late 1990's)
Virginia Man-Yee Lee post-doc Penn (Neurotree)
 (Late 1990's)
John Q. Trojanowski post-doc Penn (Neurotree)
 (Late 1990's)

Children

Sign in to add trainee
Edward B. Lee grad student Penn (Neurotree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hu WT, McMillan C, Libon D, et al. (2010) Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology. 75: 595-602
Ritson GP, Custer SK, Freibaum BD, et al. (2010) TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 7729-39
Gitcho MA, Strider J, Carter D, et al. (2009) VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. The Journal of Biological Chemistry. 284: 12384-98
Neumann M, Kwong LK, Lee EB, et al. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathologica. 117: 137-49
Weihl CC, Temiz P, Miller SE, et al. (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 1186-9
Uryu K, Nakashima-Yasuda H, Forman MS, et al. (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. Journal of Neuropathology and Experimental Neurology. 67: 555-64
Bian H, Van Swieten JC, Leight S, et al. (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology. 70: 1827-35
Grossman M, Xie SX, Libon DJ, et al. (2008) Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology. 70: 2036-45
Kimonis VE, Mehta SG, Fulchiero EC, et al. (2008) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. American Journal of Medical Genetics. Part A. 146: 745-57
Xie SX, Forman MS, Farmer J, et al. (2008) Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 126-9
See more...